Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and α1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats

Psychopharmacology

Volumn 169, Issue 3-4, 2003, Pages 247-256

  Abekawa, T ^a   Honda, M ^a   Ito, K ^a   Koyama, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1 adrenaline receptor; 5 HT2A receptor; Dopamine D4 receptor; NRA0045; Phencyclidine

Indexed keywords

2 AMINO 4 (4 FLUOROPHENYL) 5 [1 [4 (4 FLUOROPHENYL) 4 OXOBUTYL] 3 PYRROLIDINYL]THIAZOLE; 2 AMINO 4 (4 FLUOROPHENYL) 5 [1 [4 (4 FLUOROPHENYL) 4 OXOBUTYL]PYRROLIDIN 3 YL]THIAZOLE; 5 [2 [4 (3 FLUOROBENZYLIDENE) 1 PIPERIDINYL]ETHYL] 4 (4 FLUOROPHENYL)THIAZOLE 2 CARBOXAMIDE; 5 [2 [4 (3 FLUOROBENZYLIDENE)PIPERIDIN 1 YL]ETHYL] 4 (4 FLUOROPHENYL)THIAZOLE 2 CARBOXAMIDE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE 4 RECEPTOR ANTAGONIST; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; HALOPERIDOL; NEUROLEPTIC AGENT; PHENCYCLIDINE; SEROTONIN 2A ANTAGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; INFRARED RADIATION; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSOR; STEREOTYPY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLUTAMIC ACID; HALOPERIDOL; MALE; MICRODIALYSIS; MOTOR ACTIVITY; PHENCYCLIDINE; PIPERIDINES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SEROTONIN ANTAGONISTS; STEREOTYPED BEHAVIOR; THIAZOLES; TIME FACTORS;

EID: 0141924392     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1517-8     Document Type: Article

References (45)

1. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
2. Adams B, Moghaddam B (2001) Effect of clozapine, haloperidol, or M100907 on phencycIodine-activated glutamate efflux in the prefrontal cortex. Biol Psychiatry 50:750-757
3. Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589-599
4. Angrist B, Sathananthan G, Wilk S, Gershon S (1974) Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 11:13-23
5. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
6. Baldessarini RJ, Tarsy D (1980) Dopamine and the pathophysiology of dyskinesia induced by antipsychotic compounds. Annu Rev Neurosci 3:23
7. Berendse HK, Galis DE, Graaf Y, Gronewegen HJ (1992) Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316:314-347
8. Bowers MB, Morton JB (1994) Regional brain catecholamines and metabolites following THC, PCP and MK-801. Prog Neuropsychopharmacol Biol Psychiatry 18:961-964
9. 2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine-agonist-induced hyperactivity in mice. J Neural Transm 106:123-129
10. Corbett R, CamachoF, Woods AT (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74
11. Fonnum F, Mathisen SJ, Divac I (1981) Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibers in rat brain. Neuroscience 6:863-873
12. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
13. Harkin A, Morris K, Kelly JP, O'Donnell JM, Leonard BE (2001) Modulation of MK-801-induced behaviour by noradrenergic agents. Psychopharmacology 154:177-188
14. 2a serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95:735-740
15. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
16. Johnson KM (1983) Phencyclidine: behavioral and biochemical evidence supporting a role for dopamine. Fed Proc 42:2579-2583
17. Kane J, Honigfeld G, Singer J, Meltzer H, the Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796
18. Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M (2001) Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry 58:965-972
19. Kelly PH, Iversen SD (1975) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rat. Eur J Pharmacol 40:45-56
20. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS Jr (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine in humans. Arch Gen Psychiatry 51:199-214
21. Lahti, AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neurpsychopharmacology 13:9-19
22. Lindroth P, Mopper K (1979) High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Anal Chem 51:1667-1674
23. Luisada PV (1978) The phencyclidine psychosis. In: Peterson RC et al. (eds) Phencyclidine (PCP) abuse; an appraisal. NIDA Research Monograph 21. National Institute of Drug Abuse, Division of Research, Rockville, pp 241-253
24. Malhotra AK, Pinals DA, Weinberger H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307
25. Malhotra AK, Adler CM, Kennison SD, Elman I, Picker D, Breier A (1997) Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biol Psychiatry 42:664-668
26. 1-adrenoreceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367:197-206
27. Martin P, Waters N, Waters S, Carlsson A, Carlsson ML (1997) MK-801-induced hyperlocomotion: different effects of M100907, SDZ PSD 958 and raclopride. Eur J Pharmacol 335:107-116
28. Martin P, Carlsson ML, Hjorth S (1998) Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. NeuroReport 9:2985-2988
29. Mathe JM, Nomikos GG, Hildebrand BE, Hertel P, Svensson TH (1996) Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309:1-11
30. 2A receptors. Eur J Pharmacol 280:R9-R11
31. McCullough LD, Salamone JD (1992) Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens. Brain Res 577:1-9
32. 2A sites for PCP-induced locomotion in the rat. Eur J Neurosci 11:4419-4432
33. Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352
34. Nabeshima T, Yamada K, Yamaguchi K, Hiramatsu M, Furukawa H, Kameyama T (1983a) Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. Eur J Pharmacol 91:455-462
35. Nabeshima T, Yamaguchi K, Yamada K, Hiramatsu M, Furukawa H, Kameyama T (1983b) Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. Eur J Pharmacol 93:229-234
36. 2A receptor antagonist, in rats. Br J Pharmacol 121:515-525
37. 2A receptor and alpha-1 adrenoreceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl] thiazole(NRA0045). J Pharmacol Exp Ther 282:56-63
38. 4 receptor antagonist, NRA0160: a preclinical neuropharmacological profile. Life Sci 2109-2125
39. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
40. Sayed Y, Garrison JM (1983) The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs - a review. Psychopharmacol Bull 19:283-288
41. Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169-179
42. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficit sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139-154
43. 1 receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain. Eur J Pharmacol 427:211-219
44. Tanii Y, Nishikawa T, Umino A, Takahashi K (1990) Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis. Neurosci Lett 112:318-323
45. Wagstaff AJ, Bryson HM (1995) Clozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents. CNS Drugs 4:370-400